Suppr超能文献

炎症调节因子和炎症介质的基因变异与 2 型糖尿病及胰岛素抵抗的潜在相关性。

Potential associations between variants of genes encoding regulators of inflammation, and mediators of inflammation in type 2 diabetes and insulin resistance.

机构信息

Medical Faculty, Department of Medical Biology, Kutahya Health Sciences University, Kutahya, Turkey.

Medical Faculty, Department of Endocrinology, Eskisehir Osmangazi University, Eskisehir, Turkey.

出版信息

J Clin Pharm Ther. 2021 Oct;46(5):1395-1403. doi: 10.1111/jcpt.13471. Epub 2021 Jun 17.

Abstract

WHAT IS KNOWN AND OBJECTIVE

Type 2 diabetes (T2DM) is a multigenic disease that develops with impaired β-cell function and insulin sensitivity and has a high prevalence worldwide. A cause often postulated for type 2 diabetes is chronic inflammation. It has been suggested that inflammatory regulators can inhibit insulin signal transduction and that inflammation is involved in insulin resistance (IR) and the pathogenesis of type 2 diabetes. In this direction, we aimed to investigate the gene variants of MyD88 (rs1319438, rs199396), IRAK4 (rs1461567, rs4251513, rs4251559) and TRAF6 (rs331455, rs331457) and serum levels of COX-2, NF-κB, iNOS in T2DM and IR.

METHODS

The MyD88, IRAK4 and TRAF6 variations were genotyped in 100 newly diagnosed T2DM patients and 100 non-diabetic individuals using The MassARRAY® Iplex GOLD SNP genotyping method. The COX-2, iNOS and NF-κB levels were measured in serum samples with the sandwich-ELISA method. Results were analysed using SPSS Statistics software and the online FINNETI program.

RESULTS AND DISCUSSION

In our study, a total of the 7 variants in the MyD88, IRAK4 and TRAF6 genes were genotyped, and as a result, no relationship was found between most of these variants and the risk of type 2 diabetes and insulin resistance (p > 0.05). Only, the rs1461567 variant of the IRAK4 gene was significant in the heterozygous model (CC vs. CT), and the CT genotype was most frequent in diabetic individuals compared with the non-diabetics (p = 0.033). Additionally, COX-2 and iNOS levels were found to be associated with diabetes and insulin resistance (p < 0.05).

WHAT IS NEW AND CONCLUSION

Our results show that high COX-2 and iNOS levels are associated with T2DM, besides MyD88, IRAK4 and TRAF6 gene variations may not be closely related to type 2 diabetes and insulin resistance. Nevertheless, studies in this pathway with a different population and a large number of patients are important.

摘要

已知和目的

2 型糖尿病(T2DM)是一种多基因疾病,其特征是β细胞功能和胰岛素敏感性受损,并且在全球范围内具有很高的患病率。慢性炎症常被认为是 2 型糖尿病的一个病因。有研究表明,炎症调节剂可以抑制胰岛素信号转导,炎症参与胰岛素抵抗(IR)和 2 型糖尿病的发病机制。在这一方向上,我们旨在研究 MyD88(rs1319438、rs199396)、IRAK4(rs1461567、rs4251513、rs4251559)和 TRAF6(rs331455、rs331457)基因的变异与 T2DM 和 IR 患者的 COX-2、NF-κB、iNOS 血清水平之间的关系。

方法

采用 MassARRAY® Iplex GOLD SNP 基因分型方法对 100 例新诊断的 2 型糖尿病患者和 100 例非糖尿病个体进行 MyD88、IRAK4 和 TRAF6 变异的基因分型。采用夹心 ELISA 法测定血清 COX-2、iNOS 和 NF-κB 水平。结果采用 SPSS Statistics 软件和在线 FINNETI 程序进行分析。

结果和讨论

在本研究中,共对 MyD88、IRAK4 和 TRAF6 基因中的 7 个变异进行了基因分型,结果发现大多数变异与 2 型糖尿病和胰岛素抵抗的风险之间没有关系(p>0.05)。只有 IRAK4 基因的 rs1461567 变异在杂合子模型(CC 与 CT)中具有显著性,与非糖尿病患者相比,糖尿病患者的 CT 基因型更为常见(p=0.033)。此外,COX-2 和 iNOS 水平与糖尿病和胰岛素抵抗有关(p<0.05)。

新发现和结论

我们的结果表明,高 COX-2 和 iNOS 水平与 T2DM 相关,此外,MyD88、IRAK4 和 TRAF6 基因变异可能与 2 型糖尿病和胰岛素抵抗关系不密切。然而,在这一途径中,进行具有不同人群和大量患者的研究很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验